Repository logo
 

Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions.

Simple item page
cam.issuedOnline2019-03-09
cam.orpheus.successThu Jan 30 10:53:02 GMT 2020 - Embargo updated
dc.contributor.authorChamberlain, Samuel R
dc.contributor.authorGrant, Jon E
dc.contributor.orcidChamberlain, Samuel R [0000-0001-7014-8121]
dc.date.accessioned2019-01-18T00:30:17Z
dc.date.available2019-01-18T00:30:17Z
dc.date.issued2019-03
dc.description.abstractDecision-making impairments reflect tendencies towards risky or unwise choices as manifested by presence of psychiatric symptoms or cognitive impairment (e.g. representation of value, inhibitory control-response selection, learning). Such impairments are suggested by the hallmark symptoms of substance and behavioral addictions, which include escalation over time (of substance intake or a given behavior), lack of control, neglect of other domains of life, and cognitive distortions (such as 'chasing losses' in gambling disorder). Amongst the putative behavioral addictions, most epidemiological data exist for gambling disorder, which is now included in DSM-5 as a substance-related and addictive disorder. However, other disorders share parallels and may also constitute behavioral addictions, such as compulsive stealing (kleptomania), compulsive shopping, and compulsive sexual behavior. The current paper presents a narrative review of evidence for cognitive decision-making impairments in addictions, as well as pharmacological treatments of these disorders that may have relevance for improving decision-making. We find that objective decision-making deficits have been widely reported in patients with substance use disorders and gambling disorder, compared to controls. Decision-making in the other behavioral addictions is under-studied. Evidence-based pharmacological treatments for some of these addictive disorders, for example, opioid antagonists and glutamatergic agents, modulate neural systems playing key roles in decision-making. But clinical trials have seldom examined effects of such treatments on objective decision-making measures. Future research directions are discussed, including the need to include standardized outcome measures of decision-making (tasks and imaging) alongside traditional clinical measures, to better understand and enhance underlying treatment mechanisms.
dc.format.mediumPrint-Electronic
dc.identifier.doi10.17863/CAM.35454
dc.identifier.eissn1573-6660
dc.identifier.issn1040-7308
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/288138
dc.languageeng
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.publisher.urlhttp://dx.doi.org/10.1007/s11065-019-09400-z
dc.subjectDecision-making
dc.subjectGambling
dc.subjectImpulsivity
dc.subjectBehavior, Addictive
dc.subjectBrain
dc.subjectDecision Making
dc.subjectGambling
dc.subjectHumans
dc.subjectRisk-Taking
dc.subjectSubstance-Related Disorders
dc.subjectTreatment Outcome
dc.titleEfficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions.
dc.typeArticle
dcterms.dateAccepted2019-02-20
prism.endingPage102
prism.issueIdentifier1
prism.publicationDate2019
prism.publicationNameNeuropsychol Rev
prism.startingPage93
prism.volume29
pubs.funder-project-idWellcome Trust (110049/Z/15/Z)
rioxxterms.licenseref.startdate2019-03-09
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review
rioxxterms.versionAM
rioxxterms.versionofrecord10.1007/s11065-019-09400-z

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
pharm_intervens_for_decisionmaking_revised_29.8.2018.docx
Size:
209.58 KB
Format:
Microsoft Word XML
Description:
Accepted version
Licence
http://www.rioxx.net/licenses/all-rights-reserved
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
DepositLicenceAgreementv2.1.pdf
Size:
150.9 KB
Format:
Adobe Portable Document Format
Download

Collections

Cambridge University Research Outputs